Results 251 to 260 of about 1,015,161 (283)

Infection of dendritic cells by enterobacteriaceae

Medical Microbiology and Immunology, 2000
Dendritic cells (DC) are potent antigen-presenting cells that play a crucial role in initiation and modulation of specific immune responses. Various pathogens like viruses or bacteria are able to persist inside DC. In this study we investigated the ability of the Gram-negative bacteria Salmonella typhimurium and Escherichia coli to infect DC.
M, Schoppet, H I, Huppertz, A, Simm, A, Bubert   +3 more
openaire   +2 more sources

Detecting Risk and Predicting Patient Mortality in Patients with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Bloodstream Infections

Future Microbiology, 2012
Extended-spectrum β-lactamases (ESBLs) have been increasingly described worldwide, especially among Enterobacteriaceae isolates, and recently not only in the nosocomial, but also in the community setting.
Enrico Maria Trecarichi, Roberto Cauda, Mario Tumbarello   +2 more
exaly   +2 more sources

Oral enterobacteriaceae in patients with HIV infection

Journal of Oral Pathology & Medicine, 1990
160 oral swabs of 149 HIV‐infected patients and 168 swabs of 166 controls were cultured to detect a possible colonization of the oral cavity with yeasts and Enterobacteriaceae, In 5.0% of the HIV‐infected patients and in 4.8% of the controls different species of Enterobacteriaceae were found. Yeasts were always associated with Enterobacteriaceae in the
A, Schmidt-Westhausen, F J, Fehrenbach, P A, Reichart   +2 more
openaire   +2 more sources

A serologic response in human infection with Enterobacteriaceae

The American Journal of the Medical Sciences, 1977
Sera from patients infected with Escherichia coli, Proteus, Klebsiella, and Serratia were studied for precipitins to ultrasonic extracts of these organisms in gel-diffusion plates. Sera from 66 per cent of these patients contained precipitins when initially tested. Twenty-four per cent of sera tested in the first week after onset of infection contained
J C, Crowder, J P, Rissing, J W, Smith, A, White   +3 more
openaire   +2 more sources

Orthopedic Implant-Associated Infection by Multidrug Resistant Enterobacteriaceae [PDF]

Journal of Clinical Medicine, 2019
Introduction: Orthopedic implant-associated infections caused by multidrug-resistant Enterobacteriaceae are a growing challenge for healthcare providers due to their increasing incidence and the difficulties of medical and surgical treatment.
Jaime Esteban, Antonio Blanco, Joaquin García-Cañete   +2 more
exaly   +3 more sources

Treatment of infections caused by carbapenemase-producing Enterobacteriaceae

Enfermedades Infecciosas y Microbiología Clínica, 2014
Treatment of infections caused by carbapenemase-producing Enterobacteriaceae (CPE) is currently one of the most important challenges of infectious diseases. The available information is based on in vitro studies, some animal model data and a few case studies and retrospective cohorts; appropriate data are lacking or are very scarce for some old ...
Jesús, Rodríguez-Baño, José Miguel, Cisneros, Carlota, Gudiol, José Antonio, Martínez   +3 more
openaire   +2 more sources

Risk of resistant infections with Enterobacteriaceae in hospitalized neonates

The Pediatric Infectious Disease Journal, 2002
To determine the risk factors associated with progression from colonization to infection with health care-associated antimicrobial-nonsusceptible Enterobacteriaceae (ANE) in critically ill neonates.During a 3-year period (1998 to 2000), surveillance rectal cultures were performed on neonates admitted to our Level III neonatal intensive care unit after ...
Nalini, Singh, Kantilal M, Patel, Marie-Michèle, Léger, Billie, Short, Bruce M, Sprague, Nnenna, Kalu, Joseph M, Campos   +6 more
openaire   +2 more sources

ESBL-producing Enterobacteriaceae: controlling the spread of infection

British Journal of Nursing, 2007
Extended spectrum ß-lactamase (ESBL)-producing Enterobacteriaceae were first reported in Europe in the 1980s and have since become a worldwide problem. This has resulted in increased morbidity, mortality and cost in treating the infections they cause (Paterson et al, 2001; Bisson et al, 2002). In the UK the prevalence of ESBL rose from 5.4% in 1997 to
openaire   +2 more sources

Disparity in infection control practices for multidrug-resistant Enterobacteriaceae

American Journal of Infection Control, 2012
There is a lack of empiric evidence regarding the optimal approach to controlling the transmission of extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) and carbapenem-resistant Enterobacteriaceae (CRE). In this context, we expect that infection control practices for these organisms vary widely between hospitals.A survey examining ...
Christopher, Lowe, Kevin, Katz, Allison, McGeer, Matthew P, Muller   +3 more
openaire   +2 more sources

Use of meropenem in treating carbapenem-resistant Enterobacteriaceae infections

Expert Review of Anti-infective Therapy, 2019
Introduction: The epidemiology of carbapenem-resistant Enterobacterales (CRE) is increasingly worldwide. Production of carbapenemases is the most common and efficient mechanism of carbapenem resistance, and could theoretically be overcome by optimizing the pharmacokinetic/pharmacodynamic (PK/PD) behavior of meropenem.
Pascale R., Giannella M., Bartoletti M., Viale P., Pea F.   +4 more
openaire   +3 more sources